Literature DB >> 18827152

COPD-related morbidity and mortality after smoking cessation: status of the evidence.

N S Godtfredsen1, T H Lam, T T Hansel, M E Leon, N Gray, C Dresler, D M Burns, E Prescott, J Vestbo.   

Abstract

The evidence base for the benefit of quitting smoking as regards morbidity and mortality outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) is limited. The present article is a review of the existing literature. A systematic literature search in medical databases was performed until March 2006, and subsequently until September 1, 2007. The outcomes examined were COPD-related morbidity and mortality (including all-cause mortality) in COPD patients in connection with smoking cessation. A total of 21 and 27 published articles on morbidity and mortality, respectively, were identified and reviewed. For both outcomes, only a few of the studies included patients with severe COPD. Most of the studies reported a beneficial effect of smoking cessation compared with continued smoking, whereas a few found no improvement. Methodological problems, including small study sizes, poor data quality, possibility of reverse causality and incomplete ascertainment of cause of death, limit interpretation of some of the studies. The evidence as a whole supports the conclusion that, even in severe chronic obstructive pulmonary disease, smoking cessation slows the accelerated rate of lung function decline and improves survival compared with continued smoking.

Entities:  

Mesh:

Year:  2008        PMID: 18827152     DOI: 10.1183/09031936.00160007

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  99 in total

1.  Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.

Authors:  Clifford A Courville; S Vamsee Raju; Bo Liu; Frank J Accurso; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

2.  Association of socioeconomic position with health behaviors and mortality.

Authors:  Silvia Stringhini; Séverine Sabia; Martin Shipley; Eric Brunner; Hermann Nabi; Mika Kivimaki; Archana Singh-Manoux
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

3.  Smoking--a study that leaves many questions unanswered.

Authors:  Gerhard W Sybrecht
Journal:  Dtsch Arztebl Int       Date:  2010-01-29       Impact factor: 5.594

Review 4.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

5.  Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats.

Authors:  Ching-Wen Wu; Tammy Yau; Ciara C Fulgar; Savannah M Mack; Alina M Revilla; Nicholas J Kenyon; Kent E Pinkerton
Journal:  Toxicol Pathol       Date:  2019-12-24       Impact factor: 1.902

6.  "High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent.

Authors:  Pei Yee Tiew; Fanny Wai San Ko; Jayanth Kumar Narayana; Mau Ern Poh; Huiying Xu; Han Yee Neo; Li-Cher Loh; Choo Khoon Ong; Micheál Mac Aogáin; Jessica Han Ying Tan; Nabilah Husna Kamaruddin; Gerald Jiong Hui Sim; Therese S Lapperre; Mariko Siyue Koh; David Shu Cheong Hui; John Arputhan Abisheganaden; Augustine Tee; Krasimira Tsaneva-Atanasova; Sanjay H Chotirmall
Journal:  Chest       Date:  2020-02-22       Impact factor: 9.410

7.  Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Aniqa Chowdhury; Naren Vyavahare
Journal:  Biochem Biophys Res Commun       Date:  2018-03-19       Impact factor: 3.575

Review 8.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

9.  Expression profiling identifies genes involved in emphysema severity.

Authors:  Santiyagu M Savarimuthu Francis; Jill E Larsen; Sandra J Pavey; Rayleen V Bowman; Nicholas K Hayward; Kwun M Fong; Ian A Yang
Journal:  Respir Res       Date:  2009-09-02

Review 10.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.